A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer

Exclusion Criteria

• •1. Symptomatic visceral metastasis and other conditions, and the researcher judged that endocrine therapy was not suitable for use.
• •2. History of clinically serious cardiovascular disease.
• •3. The ECG examination was abnormal.
• •4. Patients with clinically significant endometrial abnormalities, including but not limited to endometrial hyperplasia and dysfunctional uterine bleeding.
• •5. The subjects were in acute infection or active tuberculosis and needed drug treatment.
• •6. The patients received surgery, chemotherapy, immunotherapy and macromolecular targeted therapy within 4 weeks before the first medication.
• •7. Pregnant and lactating women, or intending to become pregnant during the study.
• •8. There was a clear history of neurological or mental disorders and the subjects had a history of psychotropic drug abuse or drug abuse.
• •9. In the course of this study, it is expected to receive other anti-tumor treatments or drugs.